$ALLE Wells Fargo Maintains Outperform On Allegion, Raises Target To $132 As Firm Notes 'We admit that the stock multiples look healthy here, however two potential catalysts help preserve our Outperform rating near term' '1) We think that F’20 guidance (to be provided in January) has potential to surprise with better than expected org growth expectations vs current c’sus and 2) Capital deployment has potential to add up to $0.50 in EPS over the next couple of years (that itself is $10+ in stock price (or 9% appreciation potential)'